Biomerica's inFoods® IBS test is now available at Gastro Health, providing a revolutionary new treatment for patients suffering from Irritable Bowel Syndrome (IBS).GlobeNewsWire • 04/17/23
Biomerica announces the Launch of InFoods IBS as a Laboratory Developed Test (LDT); First patient samples have been processedGlobeNewsWire • 03/08/23
Biomerica Announces Closing of $8 Million Underwritten Public Offering of Common StockGlobeNewsWire • 03/07/23
Biomerica Announces Pricing of $8 Million Underwritten Public Offering of Common StockGlobeNewsWire • 03/03/23
Biomerica Reports Financial Results for Fiscal 2023 Second Quarter Ended November 30, 2022GlobeNewsWire • 01/13/23
Biomerica Appoints Mayo Clinic Gastroenterologist, Dr. Brian E. Lacy, to the Company's Scientific Advisory BoardGlobeNewsWire • 01/10/23
Biomerica Receives KFDA and Ministry of Health Approval for Colorectal Screening and Breast Screening Tests in Saudi Arabia and UAEGlobeNewsWire • 12/08/22
Biomerica InFoods® IBS Data Presented at the 2022 American College of Gastroenterology (ACG) Annual Scientific MeetingGlobeNewsWire • 11/02/22
Biomerica stock leaps as Walmart expands sales of Aware Breast Self Exam to its storesMarket Watch • 10/14/22
Walmart to Expand Sales of Biomerica's Aware® Breast Self Exam; Product will now be available in over 2400 Walmart storesGlobeNewsWire • 10/14/22
Biomerica Reports 30% Increase in Revenues for Fiscal Q1 2023 vs. Fiscal Q1 2022GlobeNewsWire • 10/13/22
Biomerica Plans Launch of InFoods® IBS Test; Names Robert Carlson as Chief Commercial OfficerGlobeNewsWire • 08/30/22
Biomerica Announces FDA Submission For a Test to Detect Helicobacter pylori (H. pylori), a Bacteria That Infects Approximately 35% of the US PopulationGlobeNewsWire • 04/26/22
Biomerica Reports 111% Increase in Q3 Fiscal 2022 Revenues to $7.6 million vs. Q3 Fiscal 2021GlobeNewsWire • 04/14/22
Biomerica Announces Positive Topline Results from the Endpoint Clinical Trial of its InFoods® IBS Treatment for Patients with Irritable Bowel SyndromeGlobeNewsWire • 02/08/22
Biomerica Reports Record Financial Results for Fiscal Second Quarter ended November 30, 2021GlobeNewsWire • 01/13/22
Biomerica Announces Preliminary Second Quarter Revenue Increase of Approximately 238%, to Approximately $4.6 MillionGlobeNewsWire • 12/16/21